Intradigm Raises $16M For RNA Interference Technology
Palo Alto-based Intradigm has raised $16M in a Series A funding, the firm said today. The round closed over five months ago, in May of this year, and was lead by Alta Partners and Frazier Healthcare Ventures. Other investors included Emerging Technology Partners (ETP), Novartis' Ventures Fund, MediBic Alliance/Daiichi and Genentech. The firm is relocating its new facilities in Palo Alto from Rockville, Maryland.
posted on Tuesday, November 21, 2006 (Link to more information)
Related companies:
Intradigm
Related stories:
> Intradigm Closes $21.4M Round
> Intradigm Gets $18.5M In Series B
> Solstice Biologics Raises $18M
> Kumu Raises $15M For Wireless Radio Technology
> Merck Buys Sirna Therapeutics
silicontap.com Home